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Celiac disease (CD), the most common chronic enteropathy worldwide, is triggered
and sustained by a dysregulated immune response to dietary gluten in genetically
susceptible individuals. Up to date either the role of environmental factors and the
pathways leading to mucosal damage have been only partially unraveled. Therefore,
we seized the unique opportunity to study a naturally-occurring experimental model of
a family composed of both parents suffering from CD (one on a gluten-free diet) and
two non-celiac daughters. The control group consisted in four unrelated cases, two
celiac and two non-celiac subjects, all matching with family members for both disease
status and genetic susceptibility. In this privileged setting, we sought to investigate gene
expression in peripheral blood mononuclear cells (PBMCs), a population known to mirror
the immune response state within the gut. To this purpose, PBMCs were obtained from
the four biopsied-proven CD patients and the four non-celiac cases. Each group included
two family members and two unrelated control subjects. After RNA purification and
cDNA synthesis, each sample underwent a microarray screen on a whole-transcriptome
scale, and the hybridization results were visualized by hierarchical clustering. Differentially
expressed genes (DEG) were partitioned into clusters displaying comparable regulations
among samples. These clusters were subjected to both functional and pathway analysis
by using the Kyoto Encyclopedia of Genes and Genomes. Interestingly, on a global
gene expression level, the family members clustered together, regardless of their disease
status. A relevant fraction of DEG belonged to a limited number of pathways, and could
be differentiated based on disease status: active CD vs. treated CD and CD vs. controls.
These pathways were mainly involved in immune function regulation, cell-cell junctions,
protein targeting and degradation, exosome trafficking, and signal transduction. Worth
of noting, a small group of genes mapping on the male-specific region of the Y
chromosome, and previously linked to cardiovascular risk, was found to be strongly
upregulated in the active CD case belonging to the family, who suddenly died of a heart
attack. Our results provide novel information on CD pathogenesis and may be useful in
identifying new therapeutic tools and risk factors associated with this condition.
Keywords: celiac disease, exosome and immune modulation, microarray analysis, pathogenesis, transcription
factors
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INTRODUCTION
Celiac disease (CD) is a high prevalent multifactorial disorder
caused by a dysregulated immune response toward both
dietary (i.e., the gluten components) and self (i.e., the enzyme
tissue transglutaminase) antigens: it has the small intestine
as the target organ and develops in genetically susceptible
individuals (1). Its clinical picture ranges from an asymptomatic
or oligosymptomatic condition to a severe malabsorption
syndrome, and its treatment is still based on a gluten-free diet
(GFD), as originally proposed by the Dutch Pediatrician, Doctor
Willem Dicke (2). It is widely accepted that genetic factors play
a crucial role, as supported by the familial occurrence of the
disease, with first-degree relatives of patients presenting with
an incidence of about 15%:10–20 times higher than the general
population (3). Concordance in dizygotic twins is 10–20% and
reaches 70–80% in monozygotic twins (4, 5). The main genetic
susceptibility factor is represented by the genomic region known
as “human leukocyte antigen” (HLA) on chromosome 6 (6p21).
This region is also known as “locus celiac 1.” Specifically, CD
is strongly associated with two HLA class II haplotypes (6).
Indeed, more than 90% of patients carry the DQ2 heterodimer,
coded by the α chain alleles DQA1 ∗0501 or ∗0505, and β
chain alleles DQB1 ∗0201 or ∗0202. The remaining carry the
DQ8 heterodimer, coded by DQA1 ∗0301 and DQB1 ∗0302
alleles, while only a few patients carry the DQB1 risk allele
(7). Both heterodimers are expressed on antigen-presenting
cells and are responsible for the high affinity to gluten peptides
and their efficient presentation to T-cells (7). An additional 40
non-HLA susceptibility loci have been identified (8, 9). Among
these, loci “celiac 2” on chromosome 5 (5q31-q33), “celiac 3”
on chromosome 2 (2q33), and “celiac 4” on chromosome 19
(19p13.1) (10–12). However, epidemiological data suggest that
further predisposing loci might exist (13). Indeed, 39% of the
general population carries the HLA DQ2 or DQ8 haplotypes,
but only 3% of them will eventually develop CD. Recent studies
point to the involvement of non-coding regions with their role in
gene expression regulation(14). Specific gene networks, as well as
environmental factors, could also contribute to mucosal lesions
(15). In other words, considering the extent and complexity
of the CD-specific dysregulated immune response, every
new contribution aimed at discovering still unidentified
genes, pathways, or factors linked to (or differentially
expressed in) this condition, may help to clarify pathogenic
routes.
This study aimed to uncover new biological pathways
involved in CD pathogenesis through a whole-transcriptome
study on peripheral blood mononuclear cells (PBMCs). Blood
was sampled from a naturally-occurring experimental setting
Abbreviations: AURE, AU-rich elements; CD, Celiac disease; DEG, Differentially
expressed genes; GFD, gluten-free diet; H-r, healthy-related; H-u, healthy-
unrelated; HLA, Human Leukocyte Antigen: : KEGG, Kyoto Encyclopedia of
Genes and Genomes; MAPK, MAP kinase; MSY, male-specific region of the Y
chromosome; PBMC, peripheral blood mononuclear cells; TCD, treated celiac
disease; TCD-r, treated celiac disease-related; TCD-u, treated celiac disease-
unrelated:; UCD, untreated celiac disease; UCD-r, untreated celiac disease-related;
UCD-u, untreated celiac disease-unrelated.
of a family composed of both parents suffering from CD (one
on a gluten-free diet) and two non-celiac daughters. A control
group was included in the study that consisted in four disease-
matched unrelated subjects: two celiac patients and two non-
celiac subjects, all carrying the classic genetic susceptibility, in
an attempt to identify further risk factors involved in disease
onset. PBMC appeared particularly suitable for this study for
several reasons. They can be harvested in a non-invasive fashion
and a wealth of published data report a continuous crosstalk
between immune cells and other compartments of the body,
comprised the digestive tract (16–18). Furthermore, PBMCs
include antigen-specific dendritic cells, T- and B-lymphocytes
which, apart from being directly responsible for the tissue
damage in the small intestine, are known to reflect events in
the target organ by recirculating from the intestinal mucosa
to peripheral blood (17). For example, a set of genes with
dysregulated expression in PBMCs has been recently defined in
pediatric CD (16), with a good discriminating potential between
patients and controls and possible diagnostic applications. In
general, peripheral blood is known to be a vehicle for transfer of
molecular signals (19, 20). This exchange is mediated primarily
by exosomes, which contain and transfer signals represented
by DNA, mRNA, microRNA, and proteins. On one hand, this
has the potential of modifying the gene expression picture of
acceptor cells, where mRNA incorporated into exosomes may be
translated and microRNA exert their regulatory role (21). On the
other hand, this exchange mediated by peripheral blood informs
the whole body about the eventual disease status of an organ
(19). Strictly related to this, it is known that gut epithelium and
immune cells, when within the gut, contain (and then release)
exosome-like vesicles that carry HLA class II/antigen complexes,
including food antigens (22, 23).
For all the reasons outlined above, the experimental setting
and PBMC samples provided us with a privileged view to
better understand the influence, and relative weight, of genetic
relatedness and environment in this complex, multifactorial
disorder.
METHODS
Experimental Cohort
All celiac patients included in the study have been diagnosed
according to the worldwide accepted criteria (i.e., positivity for
anti-tissue transglutaminase class A autoantibodies and presence
of characteristic mucosal lesions upon histology of the duodenal
mucosa) (24).
The demographic and clinical features of the eight total
patients and controls are listed in Table 1. In the table, and
hereafter in the text, each case is indicated as “cc” followed by a
number. Subjects cc1–cc4 constitute the family. Subjects cc5–cc8
are unrelated individuals, external to the family.
More in depth, cc1 (the mother) is a treated celiac patient
(TCD, “treated celiac disease”). She is also referred to as TCD-
related (TCD-r, Table 1) to underline that she belongs to the
family. She has been following a strict gluten-free diet since the
diagnosis 8 years earlier, thus her CD serology was negative
with mucosal recovery at the time of the study. The father (cc2)
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TABLE 1 | Patients and controls included in the study.
Sample code Date of birth/sex Diagnosis-relatedness/
unrelatedness
Position within the family Body mass index Comorbidities
cc1 29-06-1964/F TCD-r Mother 21.1 Miscarriage Osteopenia
cc2 16-11-1960/M UCD-r Father 23.0 Helicobacter pylori infection
cc3 18-01-1990/F H-r1 Daughter 1 20.9 Helicobacter pylori infection
cc4 27-09-1995/F H-r2 Daughter 2 22.9 None
cc5 18-11-1962/F H-u1 Unrelated 19.1 None
cc6 07-07-1978/F H-u2 Unrelated 23.4 Helicobacter pylori infection
cc7 28-12-1971/F TCD-u Unrelated 21.7 Seasonal atopy
cc8 01-01-1942/F UCD-u Unrelated 18.5 Osteoporosis Colonic diverticulosis
F, Female; M, Male; H, Healthy Control; TCD, Treated Celiac Disease; UCD, Untreated Celiac Disease; r, related; u, unrelated.
suffered from untreated celiac disease (UCD) and is referred to
as UCD-related (UCD-r). He always refused the GFD, thus both
serological and histological markers were persistently positive.
The two daughters (cc3 and cc4) are indicated as healthy-related
(H-r1 and H-r2). They both had negative serologic results in the
absence of class A immunoglobulin deficiency with an increase
in intraepithelial lymphocyte counts (respectively 41/100 and
33/100 epithelial cells) at duodenal histology.
Among the four unrelated subjects, cc5 and cc6 are non-
celiac controls diagnosed with functional dyspepsia and are also
referred to as healthy-unrelated (H-u1 and H-u2, Table 1). cc7
and cc8 are celiac patients, the former under a gluten-free diet
since three years and the latter a neo-diagnosed patient. They are
thus indicated as TCD-u (cc7) and UCD-u (cc8), respectively.
Figure 1 reports the HLA haplotypes of the enrolled subjects.
cc1 and cc3 carry two heterodimers of the classical DQ2
haplotype, while cc2 and cc6 present one heterodimer of the DQ2
haplotype, as cc7 and cc8. Both daughters (cc3 and cc4) inherited
different combinations of the parental HLA loci. Finally, cc4
carries two alleles of the monomer β of the DQ2 haplotype, while
cc5 displayed the monomer α of the DQ2 and a monomer β of
the DQ8 susceptibility haplotypes.
Sample Collection
A 10mL sample of whole peripheral blood was drawn from
each subject at the Gastroenterology Unit, Policlinico G.B. Rossi,
AOUI Borgo Roma (Verona, Italy) and collected in EDTA
for immediate processing. Sample collection was conducted in
accordance with the World Medical Association’s Declaration
of Helsinki, and it was approved by the local Ethics Committee
for Clinical Sperimentation (CESC) of Verona and Rovigo. Each
enrolled subject gave written informed consent to participate in
the study and did not have any acute illness at the time of blood
harvest unless those specified in Table 1.
Peripheral Blood Mononuclear Cells and
RNA Isolation
PBMCs were purified using the Lympholyte R©-H (Cedarlane;
Toronto, Canada) density gradient. Total RNA was then
extracted with a trizol-based procedure (TRI Reagent, Sigma
Aldrich; St. Louis, MO). RNA was quantified using a NanoDrop
spectrophotometer (Agilent; Santa Clara, CA) and quality-
checked using a Bioanalyser 2100 (Agilent, RNA 6000 Nano
Assay).
Microarray Hybridization and Data Analysis
Microarray experiments were performed by the Genopolis
Consortium (University of Milano-Bicocca; Milan, Italy) using
the Affymetrix HumanU133PLUS2GeneChip R©technology (54K
probes) according to standard protocols. Hybridized arrays were
scanned using the GeneArray scanner, and the resulting images
analyzed with the Affymetrix GeneChip Operating Software
(GCOS). Quality scores were then inferred for each spot,
background subtracted with the GCRMA algorithm, and signal
intensities normalized using qSpline (25). Quality-filtering was
performed by removing all probesets whose values were not
significantly different from control values or below the 95th
percentile. Differentially expressed genes (DEG), i.e., genes
whose expression resulted significantly different between a
given sample and the one chosen as the reference (common
baseline), were selected among the quality-filtered probesets. The
FoldChange method was used and expression values expressed
as log2 ratios. Hierarchical clustering and heatmap analyses
were used to group samples by their expression patterns.
Finally, the Partitioning Around Medoid-clustering method
(26) was used to partition the gene expression profiles into k
clusters of genes presenting similar regulation profiles among
samples.
Gene and Pathway Analysis
To define biological functions and processes associated with
DEG, information from ENSEMBL (ensembl.org) and NCBI
(ncbi.nlm.nih.gov) was mutated. Within NCBI, the OMIM
(Online Mendielian Inheritance in Man) and UniGene datasets
were screened. Gene pathways were analyzed according to
either the Kyoto Encyclopedia of Genes and Genomes (KEGG,
genome.jp/kegg) and the Gene Ontology (GO, http://www.
informatics.jax.org) tools. The p-value was calculated for the
pathways associated with DEG of the various clusters, against the
null hypothesis that the enrichment for a particular pathway is
random. A p-value <0.05 was considered statistically significant.
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FIGURE 1 | Genogram representing the cohort of subjects recruited for the study. Familiar relations and HLA alleles at the DQA1 and DQB1 loci are reported.
RESULTS
Microarray Analysis
Total RNA extracted from PBMCs of the eight subjects was
used for the microarray hybridization. A total of 20,300 out of
54,675 probesets on the array passed the filters and underwent
downstream analyses. Samples were first grouped on the basis
of their overall expression profiles, and a distance measurement
was used to verify the quality of replicas. Resulting dendrograms
provide an unbiased overview of the relationships among
samples on the basis of their overall gene expression profile
(Figure 2). It is worth noting that the family members cc1–
cc4 clustered together, regardless of their disease status. The
sharing of a common household environment and a partially
overlapping genetic background seem to shape the overall PBMC
gene expression more than the CD status. On the contrary,
the clustering of samples belonging to unrelated individuals
cc5–cc8 was dictated by the disease status. The UCD-u patient
(cc8) resulted the most diverse, while TCD-u (cc7) shared more
similarities with the two H-u (cc5 and cc6). No intermix was
observed between the family members and the external controls.
Selection and Clustering of DEG
To identify DEG, the FoldChange method was used, with
the H-u1 control (cc5) chosen as the baseline (“reference”).
Figure 3 presents the scatter plots of the DEG identified in each
sample: a total of 1,360 unique probesets resulted differentially
expressed, some of them in multiple samples. The number
of DEG ranged from a minimum of 42 observed in cc6
(the other control external to the family, resulted the most
similar to the reference cc5 in terms of overall gene expression
profile) to a maximum of 549. This number was observed in
cc8, the UCD-u case. Notably, this was also the patient that
clustered alone in the dendrogram shown in Figure 2. A further
consideration is due on the fact that cc8 is also the sample
with the highest number of up-regulated genes, whereas cc1
(TCD-r) presents the highest amount of down-regulated genes.
These data are confirmed by the heatmap analysis shown in
Figure 4. From the figure, it clearly emerges that the condition
of “treated CD” is associated with a wide “down-regulation
picture” in both cc1 and cc7, while the situation appears more
heterogeneous for the two active CD cases. Indeed, cc8 (the
most diverse sample according to Figure 2) is characterized by
a conspicuous group of up-regulated genes while in cc2 the
situation is more nuanced and closer to the daughters cc3 and
cc4. f
DEG displaying similar expression trends across the different
samples were then grouped into clusters (26). This analysis is
based on the assumption that the similarity of gene expression
profiles within a given cluster is suggestive of a similar regulation.
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FIGURE 2 | Hierarchical clustering of arrays. The vertical scale indicates
Pearson correlation coefficients as a measure of similarity. cc1 is the treated
celiac family member (mother); cc2 is the untreated celiac family member
(father); cc3 is a healthy family member (elder daughter); cc4 is a healthy family
member (youngest daughter); cc5 is the unrelated healthy control used for
comparison; cc6 is an unrelated healthy control; cc7 is an adult unrelated
treated celiac disease patient; cc8 is an adult unrelated untreated celiac
disease patient. For comments, see the text.
Based on this approach, 10 clusters were found to optimally
partition the dataset. Panels in Figure 5 report the expression
trends, along the experimental cohort, of genes belonging to each
cluster, expressed as log2 ratios vs. the reference cc5. Among
the ten clusters, several present interesting behaviors in relation
to the cohort of cases. Clusters 1, 2, 6, 9, and 10 are discussed
below.
Cluster 1: Off Switch in Celiac Patients on
a GFD
Cluster 1 groups strongly down-regulated genes in both TCD
cases (cc1 and cc7). Supplementary Table 1 lists the 80
probes whose log2 ratio calculated on cc5 was < −4 in both
patients. The relative expression with respect to the two UCD
cases (cc2 and cc8) was also assessed. A large number of
these genes is linked to the regulation of gene expression
and to cell proliferation: the resulting picture indicates an
overall silencing in TCD. Interestingly, many down-regulated
genes were involved in cell-cell and cell-matrix interactions,
vesicular and molecular trafficking, exosomes and endosomes
routes, protein ubiquitination and turnover. As shown in
Supplementary Table 1, in general the situation did not change
if calculating expression ratios vs. either cc2 or cc8 instead
of cc5. This suggests that in active CD there is a pattern
similar to healthy controls and that this pattern is then
shut down following the GFD. Table 2 reports the functional
annotation of these genes, and specifically the KEGG pathways
resulting significantly enriched among genes belonging to
cluster 1. This analysis basically confirms the scenario depicted
above. From a statistic point of view, the KEGG pathways
most significantly enriched in cluster 1 are: the JAK-STAT
signaling (p = 0.00064) followed, among others, by the T-cell
receptor cascade (p = 0.018), the Toll-like receptor signaling
(p = 0.0245) and the focal adhesion (cell-matrix adhesion,
p= 0.0302).
Clusters 2, 6 and 9: Deregulation in Active
Celiac Disease
Cluster 2 groups genes down-regulated in cc8, the UCD-u
case. Supplementary Table 2 reports the probes for which the
log2 of the ratio vs. cc5 was < −4. For the same genes, the
relative expressions vs. the TCD cases (cc1 and cc7) and vs.
one healthy daughter (cc4) are reported. As above, nearly all
of the genes result down-regulated at comparable levels in all
cases. A number of genes belonging to cluster 2 regulate cell
cycle, proliferation and apoptosis. A small group belongs to
the MAP kinase (MAPK) family. Other well-represented groups
are genes involved in cytoskeleton assembly and functions and
protein/vesicular trafficking at all levels (specifically: endosome
internalization and intracellular trafficking, transport of proteins
to the endoplasmic reticulum, post-Golgi transport, protein
docking and exocytosis, recognition of misfolded proteins and
ubiquitin cycle, cytoskeleton assembly and tight junctions).
Finally, other genes are implied in energy metabolism or
in phosphatidylinositol signaling. Table 3 presents the KEGG
functional annotation of these genes. The strongest result
reported in this table concerns the energy metabolism, and
namely, the citric acid cycle (p = 8.85 × 10−7). The MAPK
signaling pathway (p = 0.0145) is also worth of mentioning.
Concerning the protein and vesicular trafficking, further details
were obtained through the GO annotation. Among others, the
following resulted significantly enriched among DEG belonging
to cluster 2: Golgi vesicle transport (GO:0048193, p = 2.38
× 10−8); intracellular transport (GO: 0046907, p = 8.08 ×
10−8) and intracellular protein transport (GO:0006886, p = 2.26
× 10−5); secretory pathway (GO:0045045, p = 9.62 × 10−7);
vesicle-mediated transport (GO:0016192, p = 1.36 × 10−5);
endoplasmic reticulum to Golgi transport (GO:0006888, p= 2.61
× 10−4).
Cluster 6 includes a small number of genes with a very
strong up-regulation in cc2 (Supplementary Table 3). Unlike
the previous clusters, these genes do not share a function:
accordingly, no KEGG pathways resulted significantly
overrepresented. Instead they appeared to share a common
cytogenetic location on the long arm of chromosome Y,
in the region known as MSY (male-specific region of
the Y chromosome) (27). This region comprehends genes
expressed in various tissues, including also peripheral leukocytes
(28).
Finally, cluster 9 includes a large group of genes up-regulated
in UCD-u (cc8, Supplementary Table 4). In this case, cell
proliferation appeared to be strongly increased (see for example
the up-regulation of histone genes and factors promoting
proliferation and differentiation of hematopoietic precursors).
Another remarkable series of up-regulated genes are linked
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FIGURE 3 | Scatter plots of the differentially expressed genes per subject. The y-axis shows the mean of the replicates for that sample, and the x-axis is the mean
across the replicates of the sample chosen as a “reference” (cc5). Red points represent the differentially expressed genes. The distance between the two black lines is
the cutoff that defines differently expressed genes (red points).
to inflammation (cell adhesion molecules, prostaglandins,
leukotrienes, chemokines, and chemotaxis). A further well-
represented class represents genes encoding coagulation factors,
including the subunits of the heterodimeric von Willebrandt
factor. Finally, severe alterations in cytoskeleton, actin-
mediated processes, actin/myosin-mediated contraction, protein
and vesicular trafficking, protein turnover, focal adhesion,
tight junctions and cell-matrix interactions emerged. When
computing the expression ratio of these genes with respect
to cc1 (TCD-r), it appears that the functions up-regulated
in active CD are then silenced under a GFD (Supplementary
Table 4). Notably, only a part of these genes were up-regulated
also in the other untreated celiac patient, cc2. Indeed, the two
UCD of the cohort appeared to have distinct gene expression
pictures, as also evident from the clustering results in Figure 2
and the heatmap in Figure 4. Table 4 presents the KEGG
pathways significantly enriched among DEG belonging to
this cluster. These present particularly significant p-values,
as in the case of prostaglandin and leukotriene metabolism
(inflammation, p = 8.19 × 10−6); extra-cellular matrix-receptor
interaction (p = 8.06 × 10−10); cell differentiation along
the haematopoietic lineage (p = 8.37 × 10−9) and focal
adhesion (p = 3.35 × 10−5). Concerning, the coagulation
processes, the analysis conducted using the GO database
provided highly significant results: among others, GO:0050817
(coagulation) and GO:0030168 (platelet activation) resulted
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FIGURE 4 | Heatmap of the DEG universe per subject. Each probeset is
differentially expressed in at least one condition. The log2 of the ratio between
each value and the median of the row is reported on a blue-red scale.
enriched with p-values respectively of 7.72× 10−11 and=1.98×
10−5).
Cluster 10: A Family Effect or First Signs of
Future Disease?
Cluster 10 is a complex “familial” group of genes, with the parents
exhibiting opposite behaviors (cc1 down-regulated and cc2
strongly up-regulated) and the daughters cc3-cc4 also displaying
an up-regulation, but to a minor extent. Supplementary Table 5
lists the genes whose log2 was >4 for the ratio cc2/cc5
and/or<−4 for the ratio cc1/cc5. The major contribution to this
list comes from genes strongly up-regulated in cc2, and generally
slightly down-regulated in cc1. These genes fall into a few,
already mentioned, categories: cell cycle regulators (apoptosis,
DNA methylation, chromatin remodeling), gene expression
(transcription factors and mostly post-transcriptional regulation
of mRNA stability), actin cytoskeleton, vesicular and protein
trafficking. The analysis of genes up-regulated in cc2 broadly
reproduces the picture of activation of cluster 9, particularly
regarding cell proliferation. On the other hand, the same genes
were down-regulated in both TCD patients in cluster 1. Table 5
reports the KEGG pathways that were significantly enriched in
this cluster.
Figure 6, presenting the heatmap analysis performed on the
KEGG pathways, summarizes all the findings described above.
DISCUSSION
The unique possibility to study the naturally-occurring
experimental model of a family where both parents were
suffering from CD (one active and one treated) while their two
daughters were not, has allowed us to address the PBMC gene
expression in celiac patients in an original way. Within this
family, factors other than the classical genetic susceptibility may
have contributed to the development of an overt disease in two
out of four members. Four unrelated individuals were added to
the study, all of which carried the same genetic susceptibilities
to celiac disease found within the family. These non-related
individuals were meant to better unravel the relevance of factors
other than genetics and comprehended two controls and two
celiac patients (one under gluten-free diet) to mirror what was
occurring within the family. To our knowledge, a comparable
cohort of patients has never been addressed and analyzed to
define the PBMC gene expression, and this represent a novelty
that this study brings to the literature, despite its limitations.
These are linked to the fact that a limited number of subjects
is included and that the work reflects a unique, non-repeatable
situation that ended in the past. Indeed, one member of the
family, namely the father, died from a heart attack a few months
later being enrolled in this study, the mother developed a
B-cell lymphoma localized in the central nervous system, while
the clinical findings of the others (especially the daughters)
meanwhile have probably evolved and are no longer similar to
what we have pictured through the microarray analysis presented
here.
The overall picture emerging from the analysis of PBMC gene
expression on one hand confirms and enlarges several previous
findings, referring either to intestinal mucosa and blood, and on
the other hand provides useful hints to pathways/mechanisms
implied in CD pathogenesis.
The PBMC gene expression picture that emerged in TCD, in
accordance with published data (29) mirrors an overall silencing
of several functions, including cell-matrix interactions, vesicular
and molecular trafficking, cell activation and proliferation
(clusters 1 and 10). This could be suggestive of the fact that the
GFD does not restore PBMCs to a “physiological” status (30), but
rather it switches off abnormally activated pathways.
The situation in UCD appears specular: cluster 9 and, to a
minor extent, cluster 10 show how cell proliferation is strongly
pushed (31), presumably in compensation for the exaggerated
apoptosis affecting the intestinal mucosa (32). Looking in
particular at Cluster 10, it seems reasonable to hypothesize that
both daughters (cc3 and cc4) are at high risk of developing
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FIGURE 5 | Clustering of differentially expressed genes. Expression profiles of genes belonging to the 10 clusters that partition the dataset (log2 ratios). The red line
represents the general pattern that characterizes each cluster. The Y axis represents up- and down-regulations. The X axis reports samples (cc1–cc8). The “baseline”
sample (cc5) is the first on the left: the corresponding expression values are always assumed to be = 0.
a gluten-dependent enteropathy, thus they are followed closely
with serological and clinical monitoring every six months. At
present they still have a negative serology.
Two notable groups of genes up-regulated in UCD
(cluster 9) are linked to inflammation (i.e., cell adhesion
molecules, prostaglandins, leukotrienes, chemokines, and
chemotaxis) and blood coagulation. This is consistent with
data on other inflammatory conditions (33). For example, in
dermatitis herpetiformis, the so-called CD of the skin (1), the
contemporary activation of these two pathways is thought
to represent a pathogenic mechanism (34). Additionally,
impaired coagulation in UCD has recently been reported.
This leads to a hypercoagulability status and increased venous
thromboembolism, with an augmented stroke risk (35).
Finally, one of the genes involved in the inflammatory process
(OLFM4) is already reported to be up-regulated in PBMCs
together with inflamed colonic mucosa in active ulcerative
colitis (30).
Severe alterations were also found in cytoskeleton and
its functions, focal adhesion, tight junctions and cell-matrix
interactions, actin-mediated processes and actin/myosin
contraction, protein and vesicular trafficking at all levels. This is
consistent with several recent reports (29, 36–39).
In particular, the differential expression of contraction genes
(in addition to cell proliferation and tight-junction genes) has
been reported in the intestinal mucosa and PBMCs of pediatric
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TABLE 2 | Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation of
differentially expressed genes (DEG) belonging to cluster 1 (genes down-regulated
in treated celiac disease patients: cc1 and cc7).
KEGG ID Description p
04630 Jak-STAT signaling 0.00064
04660 T cell receptor pathway 0.018
04640 Hematopoietic cell lineage 0.0238
04620 Toll-Like receptor signaling 0.0245
04510 Focal adhesion (cell-matrix adhesions) 0.0302
04060 Cytokine-receptors interactions 0.0358
04210 Apoptosis 0.0433
04810 Regulation of actin cytoskeleton 0.0445
04910 Insulin signaling 0.0471
Only KEGG pathways that result significantly regulated (p-value < 0.05 against the null
hypothesis that their enrichment in DEG is random) are given in the Table.
TABLE 3 | Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation of
differentially expressed genes (DEG) belonging to cluster 2 (genes down-regulated
in the untreated celiac disease patient: CC8).
KEGG ID Description p
00020 Citrate cycle (TCA cycle) 8.85 × 10−7
04620 Toll-Like receptor signaling 0.000143
00760 Nicotinate and nicotinamide metabolism 0.00213
00564 Glycerophospholipid metabolism 0.00488
04010 MAPK signaling pathway 0.0145
04660 T cell receptor signaling pathway 0.0163
04514 Cell adhesion molecules (CAMs) 0.0385
Only KEGG pathways that result significantly regulated (p-value < 0.05 against the null
hypothesis that their enrichment in DEG is random) are given in the Table.
CD cases (32), with some genes being down-regulated and
others up-regulated, and normalization after two years of GFD.
In addition, the expression of tight junction proteins resulted
dysregulated in biopsies from UCD (38, 39). Finally vesicular
trafficking has been found to be heavily impaired in CD, mainly
as a consequence of the binding of actin filaments to gliadin
(29, 40).
The overall picture of strong impairment of cytoskeleton
structures and protein/vesicular trafficking in PBMC of active
celiac patients is indicative of a passage of “information” from
the inflamed intestinal mucosa to peripheral blood cells. In other
words, our data depict a situation where PBMCs of UCD patients
are experiencing an intense cross-talk with the gut mucosa, that
is then silenced after the introduction of a GFD. This cross-talk is
possibly mediated by exosomes.
Linked to this, the finding on the up-regulation, in UCD,
of genes coding for the heterogeneous ribonuclear protein
family (cluster 10). These genes have been precisely proposed
to control sorting and inclusion of miRNA into exosomes
(41). The remarkable number of over-expressed genes linked
to protein ubiquitination is probably also linked to this.
Indeed, it is known that sorting into exosomes of integral
TABLE 4 | Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation of
differentially expressed genes (DEG) belonging to cluster 9 (genes up-regulated in
the untreated celiac disease patient: CC8).
KEGG ID Description p
04512 Extra-cellular matrix-receptor interaction 8.06 × 10−10
04640 Hematopoietic cell lineage 8.37 × 10−9
00643 Styrene degradation 8.74 × 10−7
00590 Prostaglandin and leukotriene metabolism 8.19 × 10−6
04510 Focal adhesion 3.35 × 10−5
04610 Complement and coagulation cascade 0.000131
04810 Regulation of actin cytoskeleton 0.000529
04330 Notch signaling 0.00128
04540 Gap junction 0.00951
00350 Tyrosine metabolism 0.011
00230 Purine metabolism 0.019
04020 Calcium signaling pathway 0.0193
04060 Cytokine-cytokine receptor interaction 0.0262
00564 Glycerophospholipid metabolism 0.0267
Only KEGG pathways that result significantly regulated (p-value < 0.05 against the null
hypothesis that their enrichment in DEG is random) are given in the Table.
TABLE 5 | Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation of
differentially expressed genes (DEG) belonging to cluster 10 (genes up-regulated
in c2-c4 and down-regulated in c1).
KEGG ID Description p
04110 Cell cycle 0.00181
04510 Focal adhesion 0.00432
04810 Regulation of actin cytoskeleton 0.00472
Only KEGG pathways that result significantly regulated (p-value < 0.05 against the null
hypothesis that their enrichment in DEG is random) are given in the Table.
membrane proteins occurs through ubiquitination (19). Among
the membrane integral proteins known to be included into
exosomes, it is worth mentioning the HLA class II proteins,
included the cases where they are bound to food antigens
(22, 23).
Our data also witness the strong dysregulation of MAPK
signaling and energy metabolism in CD. Energy metabolism,
in particular the citric acid cycle, glycolysis and amino acid
metabolism, resulted impaired in a recent NMR-based study
of the gastrointestinal mucosa of active CD (42). Western-blot
analysis on PBMCs of UCD patients confirmed that MAPK
signaling was down-regulated (43).
In summary our results depict an overall switching-off in TCD
and hyper-activation in UCD, where dangerous signals are likely
spread from the inflamed intestinal mucosa (22) to other sites in
the body by circulating blood cells (16, 17).
Finally, it is worth mentioning the finding on the strong
up-regulation, in cc2, of physically adjacent genes located in
the same region of the Y chromosome, the so-called MSY.
This region is reportedly associated with coronary artery disease
(44), and the up-regulation of specific genes within it (namely
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FIGURE 6 | Heatmap of the KEGG pathways per subject. The log2 of the ratio between each value and the median of the row is reported on a blue-red scale.
EIF1AY and USP9Y, as found in cc2, see Supplementary Table 3)
specifically linked with idiopathic heart failure (45). Indeed,
cc2 died suddenly from myocardial infarction. We think that
these preliminary findings could deserve further investigation
as adulthood CD is reportedly associated with an increased
cardiovascular morbidity, whose pathogenic bases are still poorly
understood (46, 47).
In conclusion, our results highlight an extensive, gluten-
dependent, dysregulation, in peripheral blood cells, in the
expression of genes encoding for a number of pathways
that contribute to CD pathogenesis, together with a strong
effect of the environment in shaping their expression.
Furthermore, microarray technology still appears a powerful
tool for investigating new therapeutic targets, and circulating
mononuclear cells were confirmed to be an essential source of
information on mucosal immunity in celiac patients.
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